186 related articles for article (PubMed ID: 37707375)
41. Total Gastrectomy for Hereditary Diffuse Gastric Cancer at a Single Center: Postsurgical Outcomes in 41 Patients.
Strong VE; Gholami S; Shah MA; Tang LH; Janjigian YY; Schattner M; Selby LV; Yoon SS; Salo-Mullen E; Stadler ZK; Kelsen D; Brennan MF; Coit DG
Ann Surg; 2017 Dec; 266(6):1006-1012. PubMed ID: 27759617
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
43. Prophylactic Laparoscopic Total Gastrectomy with Jejunal Pouch Reconstruction in Patients Carrying a CDH1 Germline Mutation.
Haverkamp L; van der Sluis PC; Ausems MG; van der Horst S; Siersema PD; Ruurda JP; Offerhaus GJ; van Hillegersberg R
J Gastrointest Surg; 2015 Dec; 19(12):2120-5. PubMed ID: 26443527
[TBL] [Abstract][Full Text] [Related]
44. Two independent families with strongly suspected hereditary diffuse gastric cancer based on the probands' endoscopic findings.
Iwaizumi M; Yamada H; Fukue M; Maruyama Y; Sonoda A; Sugimoto M; Koda K; Kushima R; Maekawa M; Sugimura H
Clin J Gastroenterol; 2020 Oct; 13(5):754-758. PubMed ID: 32594425
[TBL] [Abstract][Full Text] [Related]
45. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
46. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
Cisco RM; Norton JA
Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
[TBL] [Abstract][Full Text] [Related]
47. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
48. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
49. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
[TBL] [Abstract][Full Text] [Related]
50. Case series of three patients with hereditary diffuse gastric cancer in a single family: Three case reports and review of literature.
Hirakawa M; Takada K; Sato M; Fujita C; Hayasaka N; Nobuoka T; Sugita S; Ishikawa A; Mizukami M; Ohnuma H; Murase K; Miyanishi K; Kobune M; Takemasa I; Hasegawa T; Sakurai A; Kato J
World J Gastroenterol; 2020 Nov; 26(42):6689-6697. PubMed ID: 33268956
[TBL] [Abstract][Full Text] [Related]
51. Outcomes of screening gastroscopy in first-degree relatives of patients fulfilling hereditary diffuse gastric cancer criteria.
van der Post RS; van Dieren J; Grelack A; Hoogerbrugge N; van der Kolk LE; Snaebjornsson P; Lansdorp-Vogelaar I; van Krieken JH; Bisseling TM; Cats A
Gastrointest Endosc; 2018 Feb; 87(2):397-404.e2. PubMed ID: 28455161
[TBL] [Abstract][Full Text] [Related]
52. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
53. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
Black MD; Kaneshiro R; Lai JI; Shimizu DM
Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
[TBL] [Abstract][Full Text] [Related]
54. Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.
Benusiglio PR; Colas C; Guillerm E; Canard A; Delhomelle H; Warcoin M; Bellanger J; Eyries M; Zizi M; Netter J; Soubrier F; Parc Y; Mourregot A; Maran Gonzalez A; Cusin V; Denis JA; Coupier I; Svrcek M; Coulet F
Gastric Cancer; 2019 Jul; 22(4):899-903. PubMed ID: 30515673
[TBL] [Abstract][Full Text] [Related]
55. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
56. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
57. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
58. Surveillance Endoscopy in the Management of Hereditary Diffuse Gastric Cancer Syndrome.
Friedman M; Adar T; Patel D; Lauwers GY; Yoon SS; Mullen JT; Chung DC
Clin Gastroenterol Hepatol; 2021 Jan; 19(1):189-191. PubMed ID: 31678201
[TBL] [Abstract][Full Text] [Related]
59. Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.
Gullo I; Devezas V; Baptista M; Garrido L; Castedo S; Morais R; Wen X; Rios E; Pinheiro J; Pinto-Ribeiro I; Ferreira RM; Preto J; Santos-Antunes J; Marques M; Campos M; Almeida F; Espinheira MDC; Amil Dias J; Figueiredo C; Oliveira C; Trindade E; Carneiro F
Gastrointest Endosc; 2018 Jun; 87(6):1566-1575. PubMed ID: 29454568
[TBL] [Abstract][Full Text] [Related]
60. Factors associated with detection of hereditary diffuse gastric cancer on endoscopy in individuals with germline CDH1 mutations.
Laszkowska M; Tang L; Vos E; King S; Salo-Mullen E; Magahis PT; Abate M; Catchings A; Zauber AG; Hahn AI; Schattner M; Coit D; Stadler ZK; Strong VE; Markowitz AJ
Gastrointest Endosc; 2023 Sep; 98(3):326-336.e3. PubMed ID: 37094689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
